News / Health

Test of New Dengue Vaccine Shows Promise

A boy with dengue fever receives medical oxygen while laying on a bed at the Quirino hospital in Quezon city in the suburbs of Manila, August 14, 2012.A boy with dengue fever receives medical oxygen while laying on a bed at the Quirino hospital in Quezon city in the suburbs of Manila, August 14, 2012.
x
A boy with dengue fever receives medical oxygen while laying on a bed at the Quirino hospital in Quezon city in the suburbs of Manila, August 14, 2012.
A boy with dengue fever receives medical oxygen while laying on a bed at the Quirino hospital in Quezon city in the suburbs of Manila, August 14, 2012.
Faith Lapidus
A clinical trial of a new vaccine against dengue fever shows progress toward fighting the most common mosquito-borne disease.  The drug is less successful than hoped, but seems to be effective at preventing three of the four related viruses that cause dengue.

Dengue fever increasing

Dengue fever is endemic across the tropics, with more than 2.5 billion people in 128 countries at risk. Symptoms can range from aches and fever to circulatory failure, coma and death.  Some 21,000 people die of dengue each year, and the number of cases is increasing, including outbreaks in the southeastern United States.

There is no vaccine available to prevent dengue fever.  Part of the difficulty in developing one is that there are four different but related types of the disease.  Those who recover from infection by one type gain lifetime immunity, but only against that type.  Scott Halstead, of the Dengue Vaccine Initiative, explains that they are still at risk of infection with one of the other types.

"Dengue normally produces a short acute febrile disease, sort of a flu-like disease which ends in a rash, and when you're convalescent, you have life-long immunity to the type you've been infected with, say Type 1.  But you are susceptible then to either type 2 or 3 or 4, and what we've learned is that two different infections - with say, Type 1 and Type 2 - can result in a very severe catastrophic disease called dengue hemorrhagic fever, and this occurs all over the tropical world, mostly in Asia and the American tropics," Halstead explained.

New vaccine

That is why researchers are focused on developing a so-called tetravalent vaccine, modeled on the successful yellow fever vaccine, combining weakened versions of all four types of dengue virus into a single drug. 

Halstead, who was not involved in the new clinical trial, says the pharmaceutical company, Sanofi Pasteur, took a molecular approach to creating its vaccine.

"They actually spliced the gene for each of the four dengue viruses into a yellow fever backbone.  So this is a combined vaccine called a chimera, combining the yellow fever replicative machinery and the dengue surface proteins," he said. "But it is a vaccine mixture of dengue 1, 2, 3 and 4."

In the first trial to determine whether a vaccine could actually prevent the disease, Sanofi's drug was tested in 4,000 school children in Thailand.  The children got three doses of either the vaccine or a placebo.  Spacing the shots six months apart was meant to mimic the natural immune response people develop over time.  Two years later, the vaccine seemed to have protected the children against three of the four strains, but not the most common type of the virus, which accounts for about 40 percent of severe dengue cases worldwide.

But the results show that the vaccine is safe, and technologically possible.

Although Halstead and many other dengue experts expressed disappointment that Sanofi's vaccine was not more effective, they regard it as an important step forward.

"The problem is, can we use a vaccine that only protects against three?  In my commentary that I wrote for The Lancet, I speculated that maybe, if you could really give enough of a three-component vaccine to stop transmission, you'd actually leave just one virus, and one virus all by itself won't cause dengue hemorrhagic fever.  So a lot of the really serious problems caused by dengue viruses might be controlled with a three-component vaccine," said Halstead.

Sanofi is already testing its new vaccine in large Phase 3 trials involving more than 30,000 people in 10 countries, with results expected in 2014.  A report about the Phase 2 trial, and Dr. Halstead's commentary, appear in the medical journal, The Lancet.

You May Like

US Border Patrol Union Accused of Taking Sides on Immigration

Report alleges agents leaking info to immigration opponents, appearing at their private events; Center for Immigration Studies director defends agents' actions More

Video Blind Somali Journalist Defies Odds in Mogadishu

Reporting from Somali capital for past decade, Abdifatah Hassan Kalgacal has been working at one of Mogadishu's leading radio stations covering parliament More

Video Rights Monitor: Hate Groups' Use of Internet to Inflame, Recruit Growing

Wiesenthal Center's Abraham Cooper says extremists have become skilled at celebrating violence, ideology on Web More

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Hate Groups Spread Influence Via Interneti
X
Mike O'Sullivan
June 30, 2015 8:20 PM
Hate groups of various kinds are using the Internet for propaganda and recruitment, and a Jewish human rights organization that monitors these groups, the Simon Wiesenthal Center, says their influence is growing. The messages are different, but the calls to hatred or violence are similar. VOA's Mike O’Sullivan reports.
Video

Video Hate Groups Spread Influence Via Internet

Hate groups of various kinds are using the Internet for propaganda and recruitment, and a Jewish human rights organization that monitors these groups, the Simon Wiesenthal Center, says their influence is growing. The messages are different, but the calls to hatred or violence are similar. VOA's Mike O’Sullivan reports.
Video

Video US Silica Sand Mining Surge Worries Illinois Residents, Businesses

Increased domestic U.S. oil and gas production, thanks to advances known as “fracking,” has created a boom for other industries supporting that extraction. Demand for silica sand, used in fracking, could triple over the next five years. In the Midwest state of Illinois, people living near the mines are worried about how increased silica sand mining will affect their businesses and their health. VOA’s Kane Farabaugh has more in this first of a series of reports.
Video

Video Blind Somali Journalist Defies Odds in Mogadishu

Despite improving security in the last few years, Somalia remains one of the most dangerous countries to be a journalist – even more so for someone who cannot see. Abdulaziz Billow has the story of journalist Abdifatah Hassan Kalgacal, who has been reporting from the Somali capital for the last decade despite being blind.
Video

Video Texas Defies Same-Sex Marriage Ruling

Texas state officials have criticized the US Supreme Court decision giving same-sex couples the right to marry nationwide. The attorney general of Texas says last week's decision did not overrule constitutional "rights of religious liberty," and therefore officials performing wedding services can refuse to perform them for same-sex couples if it is against their religious beliefs. Zlatica Hoke reports on the controversy.
Video

Video Syrians Flee IS Advance in Hasaka

The Syrian government said Monday it has taken back one of several districts in Hasaka overrun by Islamic State militants. But continued fighting elsewhere in the northern city has forced thousands of civilians from their homes. In this report narrated by Bill Rodgers, VOA Kurdish Service reporter Zana Omer describes the scene in Amouda, where some of the displaced are taking refuge.
Video

Video Rabbi Hits Road to Heal Jewish-Muslim Relations in France

France is on high alert after last week's terrorist attack near the city Lyon, just six months after deadly Paris shootings. The attack have added new tensions to relations between French Jews and Muslims. France’s Jewish and Muslim communities also share a common heritage, though, and as far as one French rabbi is concerned, they are destined to be friends. From the Paris suburb of La Courneuve, Lisa Bryant reports about Rabbi Michel Serfaty and his friendship bus.
Video

Video S. Korea Christians Protest Gay Rights Festival

The U.S. Supreme Court decision mandating marriage equality nationwide has energized gay rights supporters around the world. Gay rights remain a highly contentious issue in a key U.S. ally, South Korea, where police did a deft job Sunday of preventing potential clashes between Christian protesters and gay activists. Kurt Achin reports from Seoul.
Video

Video Saudi Leaks Expose ‘Checkbook Diplomacy’ In Battle With Iran

Saudi Arabia’s willingness to wield its oil money on the global diplomatic stage appears to have been laid bare, after the website WikiLeaks published tens of thousands of leaked cables from Riyadh’s Ministry of Foreign Affairs. VOA's Henry Ridgwell reports.
Video

Video Nubians in Kenya Face Land Challenges

East Africa's ethnic Nubians have a rich cultural history that dates back thousands of years, but in Kenya they are facing hardships, including the loss of lands they have lived on for generations. They say the government has reneged on its pledge to award them title deeds for the plots. VOA's Lenny Ruvaga reports.
Video

Video Military Experts Question New Russian Tank Capabilities

Russia has been showing off its new tank design – the Armata T-14. Designers claim it is 20 years ahead of current Western designs - and driving it feels like playing a computer game. But military analysts question those assertions, and warn the cost could be too heavy a burden for Russia’s struggling economy. Henry Ridgwell reports.
Video

Video In Kenya, Police Said to Shoot First, Ask Questions Later

An organization that documents torture and extrajudicial killings says Kenyan police were responsible for 1,252 shooting deaths in five cities, including Nairobi, between 2009 and 2014, representing 67 percent of all gun deaths in the areas reviewed. Gabe Joselow has more from Nairobi.
Video

Video In Syrian Crisis, Social Media Offer Small Comforts

Za’atari, a makeshift city in Jordan, may be the only Syrian refugee camp to tweet its activities, in an effort to keep donors motivated as the war in Syria intensifies and the humanitarian crisis deepens. Inside the camp, families say mobile phone applications help hold together families that are physically torn apart. VOA’s Heather Murdock reports.

VOA Blogs